Refreshing results…
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor
UploadParacrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia
Download from www.nature.comMissing publications? Search for publications with a matching author name.